title: [Cardiogenic pulmonary edema following β2 agonist infusion for acute, severe asthma].
abstract: We report the case of a severe acute pulmonary edema secondary to the administration of salbutamol to a patient admitted for severe asthma. The diagnosis of acute pulmonary edema was suspected on the clinical examination, chest radiography, biological (plasmatic Pro-BNP rate) and echocardiographic findings. Rapid improvement under dobutamine and mechanical ventilation argue in favour of cardiogenic pulmonary edema. The young age of our patient, the absence of history of cardiovascular disease and the chronology of this complication onset regarded to salbutamol infusion could suggest β2 agonist involvement in this event. The improvement of cardiac function on echocardiography and the normal results obtained with myocardial perfusion scintigraphy performed 35 days later show the left ventricular reversible dysfunction.
authors.affiliation: Service de réanimation médicale, CHU Habib Bourguiba, route el Ain Km 1, 3029 Sfax, Tunisie. Electronic address: bahloulmab@yahoo.fr.
authors.forename: M
authors.initials: M
authors.lastname: Bahloul
authors.affiliation: Service de réanimation médicale, CHU Habib Bourguiba, route el Ain Km 1, 3029 Sfax, Tunisie.
authors.forename: A
authors.initials: A
authors.lastname: Chaari
authors.affiliation: Service de réanimation médicale, CHU Habib Bourguiba, route el Ain Km 1, 3029 Sfax, Tunisie.
authors.forename: H
authors.initials: H
authors.lastname: Dammak
authors.affiliation: Service de réanimation médicale, CHU Habib Bourguiba, route el Ain Km 1, 3029 Sfax, Tunisie.
authors.forename: F
authors.initials: F
authors.lastname: Medhioub
authors.affiliation: Service de cardiologie, CHU Hédi Chaker, Sfax, Tunisie.
authors.forename: L
authors.initials: L
authors.lastname: Abid
authors.affiliation: Service de médecine nucléaire, CHU Habib Bourguiba, Sfax, Tunisie.
authors.forename: K
authors.initials: K
authors.lastname: Chtourou
authors.affiliation: Service de réanimation médicale, CHU Habib Bourguiba, route el Ain Km 1, 3029 Sfax, Tunisie.
authors.forename: N
authors.initials: N
authors.lastname: Rekik
authors.affiliation: Service de réanimation médicale, CHU Habib Bourguiba, route el Ain Km 1, 3029 Sfax, Tunisie.
authors.forename: H
authors.initials: H
authors.lastname: Chelly
authors.affiliation: Service de réanimation médicale, CHU Habib Bourguiba, route el Ain Km 1, 3029 Sfax, Tunisie.
authors.forename: H
authors.initials: H
authors.lastname: Kallel
authors.affiliation: Service de réanimation médicale, CHU Habib Bourguiba, route el Ain Km 1, 3029 Sfax, Tunisie.
authors.forename: M
authors.initials: M
authors.lastname: Bouaziz
mesh_terms: D000208:Acute Disease; D058666:Adrenergic beta-2 Receptor Agonists / Q000008:administration & dosage* / Q000009:adverse effects*; D000328:Adult; D000420:Albuterol / Q000008:administration & dosage* / Q000009:adverse effects*; D001249:Asthma / Q000188:drug therapy*; D003131:Combined Modality Therapy; D004280:Dobutamine / Q000627:therapeutic use; D004452:Echocardiography; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D011654:Pulmonary Edema / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D012121:Respiration, Artificial; D012131:Respiratory Insufficiency / Q000188:drug therapy*; D018487:Ventricular Dysfunction, Left / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy
chemical_list: D058666:Adrenergic beta-2 Receptor Agonists; D004280:Dobutamine; D000420:Albuterol